DIASTAT(R) ANA (anti-Nuclear antibody) EURO DIAGNOSTICA
Recall Z-2627-2017, part of FDA recall event 77426. See Euro-Diagnostica's company page.
Euro Diagnostica AB started this Class III device recall on May 22, 2017 (voluntary: firm initiated); FDA lists it as terminated, terminated Mar 31, 2021.
- Classification: Class III
- Started: May 22, 2017
- Status: Terminated
FANA200 kit lot TS 3577 was re-worked due to shortened shelf-life. The alert sticker on the kit box of the lot informed customers that the shelf-life had been shortened and referenced a letter sent to customers for more information, where the new expiration date was stated. The original kit box label remained on the kit box stating the original expiration date, the packaging did not display the correct expiration date.
- Product
- DIASTAT(R) ANA (anti-Nuclear antibody) EURO DIAGNOSTICA, The DIASTAT(R) anti-nuclear antibody (ANA) test is a qualitative enzyme-linked immunosorbent assay (ELISA) for the detection of ANAs in human serum or EDTA plasma. It detects ANAs against Sm, Sm/RNP, Ro (SS-A), La (SS-B), Scl-70, Jo-1, dsDNA, histone and centromere antigens.
- Quantity
- 501 units
- Lots and codes
- TS 3577
- Distribution
- MN, TX, NE, PA, Spain, Egypt, Pakistan, Nepal, Canada
- Recalling firm
- Euro Diagnostica AB, Malmo, N/A, Sweden
- How the firm notified
- FDA classified
- Jun 23, 2017
- Euro Diagnostica DIASTAT ANA (anti-nuclear antibody) ELISA DIASTAT ANA (anti-nuclear antibody) A positive ANA test…Z-0306-2018 · Class II · Feb 14, 2017 · Terminated
- is a quantitative/qualitative enzyme-linked immunosorbent assay (ELISA) for the detection of IgG and IgM autoantibodies…Z-2921-2018 · Class III · Oct 21, 2016 · Terminated
- Immunoscan CCPlus test kit is an enzyme-linked immunosorbent assay (ELISA) for qualitative and semiquantitative…Z-2918-2018 · Class II · Feb 14, 2016 · Terminated
- DIASTAT anti-Nuclear antibody (ANA) / DIASTAT ANA ELISA. Catalog Number: FANA200. Product Usage: The DIASTAT…Z-0929-2018 · Class II · Oct 15, 2015 · Terminated
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports